Metadvice resources


By Andrew Krentz, 18 March 2024

Defects of insulin secretion and/or action are central to the expanding worldwide pandemic of non-communicable cardiometabolic disorders. In recent decades, large scale human overnutrition has fuelled exploding rates of obesity and type 2 diabetes. Uncommon a century ago, type 2 diabetes now affects around 1 in 10 adults worldwide …

By Andrew Krentz, 21 November 2023

A staggering one-third of the global population may harbour metabolic dysfunction associated fatty liver disease (MAFLD). This burgeoning, obesity-related health crisis is projected to escalate, with obesity rates expected to jump from 15% in 2023 to ~25% by 2035. Metadvice stands at the forefront of this challenge, leveraging AI to empower clinicians in managing the complex web of chronic diseases, particularly where metabolic and cardiovascular disorders intersect. In this blog, we draw on new evidence to explore how Metadvice technology can address this growing disease area.

By Metadvice, 23 September 2022

Metadvice is proud to announce that it started a collaboration with the Inselspital (Bern, Switzerland) supported by the Swiss innovation agency (Innosuisse) for a new project entitled: AI Companion for Diabetes Optimisation using Digital Data from Continuous Glucose Monitoring.

By Johnson & Johnson, 29 April 2022

On April 29 – the International Day of Immunology – Johnson & Johnson Innovation, together with Janssen Research & Development, announced that Metadvice and three other companies were awardees of the Immunology Innovations QuickFire Challenge: Precision Medicine in Immune-Mediated Disease.